Objectives-The aim of this study was to determine if neutrophils isolated from the blood and synovial fluid of patients with rheumatoid arthritis had patterns of receptor expression resembling those of blood neutrophils from controls which had been activated and primed in vitro. Methods-Fluorescence activated cell sorting was used to measure receptor expression in paired blood and synovial fluid neutrophils from patients and in control neutrophils exposed to phorbol myristate acetate and granulocytemacrophage colony stimulating factor. Results-There was no significant difference in the patterns of receptor expression in blood neutrophils from patients and healthy controls, but neutrophils in the synovial fluid had been primed and activated within the joint. About 50% of rheumatoid synovial fluid neutrophil samples expressed Fcy RI, a high affinity receptor for monomeric IgG, which is only expressed in neutrophils exposed to cytokines. Conclusions-Synovial fluid neutrophils are activated and primed within the inflamed joint and hence their ability to respond to activating factors such as immune complexes will be modulated. As the expression of Fcy RI requires active biosynthesis, this work indicates that selective gene activation occurs when neutrophils are recruited into rheumatoid joints.
During the active phase of rheumatoid arthritis (RA), neutrophils constitute between 60 and 80% of the total cell population of synovial fluid.' Neutrophils are cells of considerable cytotoxic potential and their inappropriate activation has been implicated in the pathogenesis of RA, perhaps through the generation of reactive oxygen metabolites such as hydrogen peroxide.2 Tissue damage may be promoted indirectly by the extracellular leakage of toxic products from accumulated neutrophils.3 Indeed, oxidant damaged products are present in synovial fluid4 and the oxidase function of neutrophils isolated from synovial fluid has been downregulated, indicating that reactive oxidant generation has been activated in vivo. 5 Furthermore, synovial fluid from patients with RA contains myeloperoxidase in a molecular form indicating that it has been co-secreted from neutrophils concomitant with reactive oxidants. 6 The mechanisms by which neutrophils are activated within rheumatoid joints and the synovial fluid factors which result in such activation are incompletely defined.
The function of neutrophils in vivo is regulated by the levels of expression of specific plasma membrane receptors including those for complement components (CR1 and CR3) and IgG molecules (Fc RI, II, and III). On cellular activation the complement receptors are upregulated whereas Fc RIII is shed from the surface of the cell7 8: Fc RII expression remains constant after cell activation whereas Fc RI is only expressed after in vitro culture of the neutrophils with interferon y.' Neutrophil function is also regulated by the activities of cytokines such as granulocyte-macrophage colony stimulating factor (GM-CSF), tumour necrosis factor, and interferon y which prime the cells into a state of enhanced responsiveness. On priming, reactive oxidant production is increased together with the levels of expression of several surface receptors.'0-12 As such cytokines have been found in the synovial fluid of patients with RA,'3 it is likely that these or other similarly acting agents will upregulate neutrophil function in situ within inflamed joints.
In this work we studied the expression of neutrophil plasma membrane receptors using monoclonal antibodies and fluorescence activated cell sorting (FACS) analysis in paired bloodstream and synovial fluid neutrophils from patients with RA. We propose that the changes in membrane expression observed in synovial fluid neutrophils may be caused by the presence of activating factors, perhaps functioning in combination with cytokines within the synovial fluid, to modulate neutrophil responsiveness.
Subjects and methods

PATIENTS
Twelve patients (two men, 10 women) with seropositive RA were studied. Six patients were receiving non-steroidal anti-inflammatory drugs (NSAIDs), one in combination with sulphasalazine. Two patients were receiving prednisolone and three were not receiving any treatment at the time of study. In addition, one patient with seronegative arthritis and another with psoriatic arthritis (both receiving NSAIDs) were studied. Figure 1 Receptor expression in primed and activated bloodstream neutrophils. Neutrophils isolatedfrom the blood of healthy controls were resuspended in RPMI (1 x 107/ml) and incubated at 37°C in tle absence (---) or presence ( ) of 041 ug/ml phorbol myristate acetate (B, D, F) for 15 minutes or with 50 U/ml granulocyte-macrophage colony stimulating factor ( ) for 60 minutes (A, C, E). After these incubations the cells were stainedforfluorescence activated cell sorting analysis as described under Subjects and methods. Similar results were obtained in 10 other experiments.
patients compared with those of healthy controls (table 1). Table 2 indicates that although the median values for CD1 lb expression are slightly higher and CD16 and 31D8 slightly lower in the peripheral blood neutrophils from rheumatoid patients these differences again did not reach significance. (fig 2A) . In contrast, fluorescence distributions after staining for CD 16 RIII), CD32 (Fc-y RII), and 31D8 were all decreased on exposure of the cells to synovial fluid. These decreases may represent decreased expression of receptors as they become intemalised or shed (especially the phosphatidylinositol linked CD 16 and 31D8) or else because binding of monoclonal antibodies is blocked by ligands present in the synovial fluid (e.g. immunoglobulins interfering with the binding of Fcy R).
When control blood neutrophils were primed with GM-CSF ( fig 2B) for one hour before the addition of synovial fluid, some differences were noted. Firstly, although priming induced an increased expression of CD1 lb, the addition of synovial fluid resulted in a further increase in expression. Secondly, whereas synovial fluid downregulated CD35 in unprimed cells, it upregulated expression in primed cells. These data indicate that whereas synovial fluid induces some effects on neutrophil receptor expression that resemble those which occur during priming in vitro, there are additional effects which may be attributable only to factors which cause activation through other mechanisms. Similar results were obtained in four other experiments using synovial fluid from different patients and control neutrophils from different donors.
Fcy RI EXPRESSION
Bloodstream neutrophils do not express CD64 (Fc-y RI), the receptor with a high affinity for monomer IgG. This receptor is only expressed after incubation of cells with interferon -y9 and the process requires activated de novo biosynthesis: incubation periods in excess of 16 hours are required before the receptor is detectable on the cell surface. In all bloodstream neutrophil preparations from controls or patients with RA, no expression of CD64 expression (using monoclonal antibody 322) could be detected. Furthermore, in five of 11 patients with RA, neutrophils in the synovial fluid expression of this receptor could not be detected ( fig 3A) . In six of 11 patients expression was detected, however ( fig 3B) . This observation indicates that these latter neutrophils have been exposed to factor(s) within the synovial fluid which have selectively activated gene expression.
Discussion
Neutrophil responses can be evoked by a variety of particulate and soluble stimuli which effect cell activation by first binding to specific cell surface receptors. Neutrophil responses in vivo are regulated by the levels of expression of these surface receptors and how they are coupled to their respective signal transduction systems. Some factors which have specific receptors on the neutrophil surface include C5a, leukotriene B4, platelet activating factor, IgG, and interleukin 8, and these have been implicated in the pathology of inflammatory joint disease.'7 18 In addition, neutrophil function may be regulated by a variety of cytokines including tumour necrosis factor'9 and GM-CSF. " 3' We therefore propose that synovial fluid neutrophils have been exposed to agents within synovial fluid which have resulted in such a selective increase in protein biosynthesis. If this phenomenon has occurred within inflamed joints then our current understanding of neutrophil function in disease pathology is grossly underestimated. Further work is necessary to identify the factors within synovial fluid which may be responsible for the regulation of receptor expression and activation of CD64 expression and also to assess the full biosynthetic activity of synovial fluid neutrophils so that their full role in disease pathology can be appreciated.
